Gimv (EBR:GIMB) | WebDisclosure

REGULATED PRESS RELEASE

published on 11/05/2025 at 07:30, 6 months 12 days ago

Gimv partners with Quality Guard to establish a leading software platform for food safety compliance across Europe
Gimv partners with Quality Guard to establish a leading software platform for food safety compliance across Europe. Quality Guard offers digital tools for HACCP, food safety, and allergen management, supported by IoT-enabled hardware

Gimv SaaS Platform European Footprint Quality Guard Food Safety Compliance
REGULATED PRESS RELEASE

published on 11/05/2025 at 07:30, 6 months 12 days ago

Gimv partners with Quality Guard to establish a leading software platform for food safety compliance across Europe
Gimv partners with Quality Guard to establish a leading software platform for food safety compliance across Europe

Gimv Partnership European Footprint Quality Guard Food Safety Compliance
REGULATED PRESS RELEASE

published on 11/05/2025 at 07:30, 6 months 12 days ago

Gimv bundelt krachten met Quality Guard om een toonaangevend softwareplatform voor voedselveiligheid in Europa uit te bouwen
Gimv investeert in Quality Guard voor toonaangevend voedselveiligheidsplatform in Europa. Samenwerking tussen Gimv en Quality Guard voor digitale compliance-oplossingen in foodservice en -retail

Gimv Compliance Europa Quality Guard Voedselveiligheid
BRIEF

published on 10/22/2025 at 07:35, 6 months 26 days ago

Gimv cède sa participation dans Imcheck Therapeutics à Ipsen

Innovation Médicale Sciences De La Vie ImCheck Therapeutics Gimv Sortie Acquisition Ipsen
BRIEF

published on 10/22/2025 at 07:35, 6 months 26 days ago

Gimv Sells Stake in ImCheck Therapeutics to Ipsen

AML Treatment ImCheck Therapeutics Ipsen Acquisition Gimv Stake Sale ICT01 Program
REGULATED PRESS RELEASE

published on 10/22/2025 at 07:30, 6 months 26 days ago

Gimv Life Sciences realiseert succesvolle exit met de verkoop van belang in Imcheck Therapeutics aan Ipsen.
Gimv realiseert succesvolle exit met verkoop belang Imcheck Therapeutics aan Ipsen. Strategische aanpak valoriseert investeringen in life sciences-sector

Gimv Ipsen Exit ImCheck Therapeutics Life Sciences-sector
REGULATED PRESS RELEASE

published on 10/22/2025 at 07:30, 6 months 26 days ago

Gimv Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen
Gimv annonce la vente de sa participation dans ImCheck Therapeutics à Ipsen, marquant une étape importante pour les deux sociétés dans le secteur des sciences de la vie

Gimv Vente Sciences De La Vie Ipsen ImCheck Therapeutics
REGULATED PRESS RELEASE

published on 10/22/2025 at 07:30, 6 months 26 days ago

Gimv Life Sciences realizes successful exit with the sale of its stake in Imcheck Therapeutics to Ipsen
Gimv Life Sciences successfully exits ImCheck Therapeutics with sale to Ipsen, creating value for shareholders and advancing medical innovation in oncology

Oncology Medical Innovation Ipsen ImCheck Therapeutics Gimv Life Sciences
BRIEF

published on 09/26/2025 at 07:35, 7 months 21 days ago

Spineart Secures CHF 25 Million to Boost Global Growth

Global Expansion Gimv EGS Beteiligungen Spineart CHF 25 Million
BRIEF

published on 09/26/2025 at 07:35, 7 months 21 days ago

Spineart renforce sa croissance mondiale avec un investissement de CHF 25 millions

Innovation Technologique Investissement Croissance Internationale Chirurgie Du Rachis Spineart

Published on 05/17/2026 at 15:20, 12 hours 10 minutes ago

China XLX Announces 2026 Q1 Results
Published on 05/16/2026 at 01:15, 2 days 2 hours ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 2 days 2 hours ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 2 days 3 hours ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 2 days 4 hours ago

Golden Minerals Reports First Quarter 2026 Financial Results

View all ACCESSWIRE

Published on 05/16/2026 at 16:08, 1 day 11 hours ago

The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 2 days 7 hours ago

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:30, 2 days 9 hours ago

Designated Person Notifications
Published on 05/15/2026 at 18:30, 2 days 9 hours ago

Designated Person Notifications
Published on 05/15/2026 at 18:10, 2 days 9 hours ago

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

View all EQS

Published on 05/15/2026 at 15:08, 2 days 12 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 12 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 17 hours ago

Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 18 hours ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 9 hours ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES

View all LES ECHOS COMFI WIRE

News